DXCM

Nasdaq

DEXCOM INC

Health Care, Health Care Equipment

$84.75

close 7 Aug 2026

+8.86%

52-week change

$31.98B

market cap

$54.11

$87.85

52-week range

Valuation

Market cap$31.98B

P/E (TTM / 5y avg)33.63x96.05x

Forward P/E (FY2026 / FY2027)31.83x27.11x

PEG (TTM / fwd)0.921.83

P/S (TTM)6.44x

P/B12.20x

EV/EBITDA (TTM)22.89x

FCF yield (TTM)4.39%

Cash flow & dividend

FCF (TTM)$1.41B

FCF per share (TTM)$3.72

FCF margin (TTM)28.27%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+13.08%

Diluted EPS YoY, latest Q+42.22%

Operating margin (TTM)22.92%

Net margin (TTM)20.12%

ROE (latest FY)30.46%

Net debt / EBITDA (TTM)0.10

Interest coverage (TTM)102.62

Price

-31.01%-7.18%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +19.33%10Y CAGR +27.77%

Diluted EPS

5Y CAGR +9.46%

FCF per share

5Y CAGR +32.10%10Y CAGR +49.26%

Operating cash flow

5Y CAGR +24.81%10Y CAGR +40.23%

Free cash flow

5Y CAGR +31.25%10Y CAGR +52.63%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR +0.02%10Y CAGR +1.65%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date28 Oct 2026

EPS estimate$0.6877

Revenue estimate$1.36B

Last reported

Date—

EPS——

Revenue——